Tactile Systems Technology, Inc. (TCMD)
NASDAQ: TCMD · Real-Time Price · USD
12.94
+0.37 (2.94%)
At close: Aug 13, 2025, 4:00 PM
12.95
+0.01 (0.08%)
After-hours: Aug 13, 2025, 4:00 PM EDT
Exscientia Revenue
Tactile Systems Technology had revenue of $78.91M in the quarter ending June 30, 2025, with 7.77% growth. This brings the company's revenue in the last twelve months to $298.85M, up 6.15% year-over-year. In the year 2024, Tactile Systems Technology had annual revenue of $292.98M with 6.76% growth.
Revenue (ttm)
$298.85M
Revenue Growth
+6.15%
P/S Ratio
1.00
Revenue / Employee
$288,188
Employees
1,037
Market Cap
288.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 292.98M | 18.56M | 6.76% |
Dec 31, 2023 | 274.42M | 27.64M | 11.20% |
Dec 31, 2022 | 246.79M | 38.73M | 18.61% |
Dec 31, 2021 | 208.06M | 20.93M | 11.18% |
Dec 31, 2020 | 187.13M | -2.36M | -1.25% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TCMD News
- 8 days ago - Tactile Systems Technology, Inc. (TCMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 23 days ago - Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025 - GlobeNewsWire
- 2 months ago - New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors - GlobeNewsWire
- 3 months ago - Tactile Medical to Present at Upcoming Investor Conferences in June - GlobeNewsWire
- 3 months ago - Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations - Benzinga
- 3 months ago - Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire